Literature DB >> 16883019

Acquisition settings for PET of 124I administered simultaneously with therapeutic amounts of 131I.

Mark Lubberink1, Annelies van Schie, Hugo W A M de Jong, Guus A M S van Dongen, Gerrit J J Teule.   

Abstract

UNLABELLED: Radiation dosimetry of thyroid cancer therapy with 131I can be performed by coadministration of 124I followed by longitudinal PET scans over several days. The photons emitted by 131I may affect PET image quality. The aim of this study was to assess the influence of large amounts of 131I on PET image quality and accuracy with various acquisition settings.
METHODS: Noise equivalent count (NEC) rates of 124I only were measured with a standard clinical PET scanner. Apart from the standard 350- to 650-keV energy window, 425- to 650-keV and 460- to 562-keV windows were used and data were acquired both with (2-dimensional) and without (3-dimensional [3D]) septa. A phantom containing 6 hot spheres, filled with a combination of 131I and 124I and with a sphere-to-background ratio of 18:1, was scanned repeatedly with energy window settings as indicated and emission and transmission scan durations of 7 and 3 min, respectively. NEC rates were calculated and compared with those measured with the phantom filled with only 124I. Sphere-to-background ratios in the reconstructed images were determined. One patient with known metastatic thyroid cancer was scanned using energy window settings and scan times as indicated 3 and 6 d after administration of 5.5 GBq of 131I and 75 MBq of 124I.
RESULTS: The highest 124I-only NEC rates were obtained using a 425- to 650-keV energy window in 3D mode. In the presence of (131)I, the settings giving the highest NEC rate and contrast were 425-650 keV and 460-562 keV in 3D mode, with the clinical scans giving the highest quality images with the same settings.
CONCLUSION: Acquisition in 3D mode with a 425- to 650-keV or 460- to 562-keV window leads to the highest image quality and contrast when imaging 124I in the presence of large amounts of 131I using a standard clinical PET scanner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16883019

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

Review 1.  Non-standard PET radionuclides: time to get ready for new clinical PET strategies.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02       Impact factor: 9.236

2.  Optimization and assessment of quantitative 124I imaging on a Philips Gemini dual GS PET/CT system.

Authors:  Rebecca A Gregory; Claire A Hooker; Mike Partridge; Glenn D Flux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-14       Impact factor: 9.236

3.  Is PET always an advantage versus planar and SPECT imaging?

Authors:  Giuliano Mariani; Laura Bruselli; Adriano Duatti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

Review 4.  Quantitative imaging of 124I and 86Y with PET.

Authors:  Mark Lubberink; Hans Herzog
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

5.  Correction technique for cascade gammas in I-124 imaging on a fully-3D, Time-of-Flight PET Scanner.

Authors:  Suleman Surti; Ryan Scheuermann; Joel S Karp
Journal:  IEEE Trans Nucl Sci       Date:  2009-06       Impact factor: 1.679

6.  A novel view on dosimetry-related radionuclide therapy: presentation of a calculatory model and its implementation for radioiodine therapy of metastasized differentiated thyroid carcinoma.

Authors:  Alexander R Stahl; Lutz Freudenberg; Andreas Bockisch; Walter Jentzen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-27       Impact factor: 9.236

7.  dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system.

Authors:  Nadège Anizan; Thomas Carlier; Cecilia Hindorf; Jacques Barbet; Manuel Bardiès
Journal:  EJNMMI Res       Date:  2012-02-13       Impact factor: 3.138

8.  Is the image quality of I-124-PET impaired by an automatic correction of prompt gammas?

Authors:  Veronika Preylowski; Susanne Schlögl; Frédéric Schoenahl; Gerhard Jörg; Samuel Samnick; Andreas K Buck; Michael Lassmann
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

9.  Optimizing reconstruction parameters for quantitative 124I-PET in the presence of therapeutic doses of 131I.

Authors:  Louise M Fanchon; Bradley J Beattie; Keith Pentlow; Steven M Larson; John L Humm
Journal:  EJNMMI Phys       Date:  2021-07-12

10.  The diagnostic value of 124I-PET in patients with differentiated thyroid cancer.

Authors:  Ha T T Phan; Pieter L Jager; Anne M J Paans; John T M Plukker; M G G Sturkenboom; W J Sluiter; Bruce H R Wolffenbuttel; Rudi A J O Dierckx; Thera P Links
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.